Abstract:PURPOSE: Hypoxia-inducible factors HIF1alpha and HIF2alpha (HIFalphas) regulate the expression of a variety of genes encoding proteins related to angiogenesis and to anaerobic metabolism of cells exposed to hypoxic stress. Their putative role as markers of clinically relevant hypoxia and, therefore, as predictors of response to chemoradiotherapy is herein examined.PATIENTS AND METHODS: Using immunohistochemistry, we assessed the expression of HIFalphas in normal head-neck mucosa and in 75 cancer specimens from patients with locally advanced squamous cell head-and-neck cancer (SCHNC), treated with concurrent carboplatin chemoradiotherapy.RESULTS: Head-and-neck mucosa from normal individuals did not show any HIF1alpha or HIF2alpha reactivity. SCHNC showed a varying expression of HIFalphas ranging through negative reactivity, to weak or focally strong cytoplasmic reactivity, or to strong diffuse cytoplasmic/nuclear reactivity. Fifty-two percent and 33% of cancer samples showed the latter expression pattern for HIF1alpha and HIF2alpha, respectively, and were considered to bear "high" HIF reactivity. Bone/cartilage involvement was more frequent in tumors with high HIF1alpha expression (p = 0.05). HIF1alpha and HIF2alpha overexpression were significantly associated with high microvessel density (p = 0.002 and 0.02, respectively) and with VEGF expression (p = 0.01 and 0.005, respectively). HIF1alpha was related to high thymidine phosphorylase expression (p = 0.03), whereas VEGF/KDR-activated tumor vasculature was significantly more frequent in HIF2alpha-overexpressing tumors (p = 0.02). High HIF1alpha and HIF2alpha were associated with incomplete response to chemoradiation (p = 0.007 and p = 0.02, respectively). In univariate analysis, high HIF1alpha and HIF2alpha expression were significantly associated with poor local relapse-free survival (p = 0.003 and 0.003, respectively) and with poor overall survival (p = 0.05 and 0.001, respectively). In multivariate models, HIF2alpha expression was an independent prognostic factor. In biopsies performed after the delivery of 20 Gy of radiotherapy, upregulation of HIFalphas was noted in some cases.CONCLUSIONS: It is concluded that the overexpression of HIFalphas in SCHNC is related to locally aggressive behavior, to intensification of angiogenesis, and to an important resistance to carboplatin chemoradiotherapy.

Hypoxia Inducible Factor-1α and Vascular Endothelial Growth Factor Expression are Associated with a Poor Prognosis in Patients with Nasopharyngeal Carcinoma Receiving Radiotherapy with Carbogen and Nicotinamide

Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression are associated with a poor prognosis in patients with nasopharyngeal carcinoma receiving radiotherapy with carbogen and nicotinamide.

Relationships Between Expression of Glucose Transporter Protein-1 and Hypoxia Inducible Factor-1Α, Prognosis and 18F-FDG Uptake in Laryngeal and Hypopharyngeal Carcinomas

Expression of Hypoxia Inducible Factor-1α in Nasopharyngeal Carcinoma and Its Clinical Value

Prognostic Value Of Hypoxia-Inducible Factor-1 Alpha In Nasopharyngeal Carcinoma: A Meta-Analysis

Meta-analysis of Immunohistochemical Expression of Hypoxia Inducible Factor-1Α As a Prognostic Role in Gastric Cancer.

The Prognostic Value of HIF-1α and VEGF Expression in Hypopharyngeal Squamous Cell Carcinoma

Prognostic Value of Vascular Endothelial Growth Factor in Patients with Head and Neck Cancer: A Meta-Analysis.

Aurora‐A Activation, Correlated with Hypoxia‐inducible Factor‐1α, Promotes Radiochemoresistance and Predicts Poor Outcome for Nasopharyngeal Carcinoma

Prospective Validation of the Prognostic Value of Elevated Serum Vascular Endothelial Growth Factor in Patients with Nasopharyngeal Carcinoma: More Distant Metastases and Shorter Overall Survival after Treatment

Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma

Hypoxia-Inducible Factor-1α (HIF-1α) Expression on Endothelial Cells in Juvenile Nasopharyngeal Angiofibroma: A Review of 70 cases and Tissue Microarray Analysis.

Fluorodeoxyglucose Uptake in Laryngeal Carcinoma is Associated with the Expression of Glucose Transporter-1 and Hypoxia-Inducible-factor-1α and the Phosphoinositide 3-Kinase/protein Kinase B Pathway.

Expression of Hypoxia-Inducible Factor 1α and Vascular Endothelial Growth Factor in Hepatocellular Carcinoma: Impact on Neovascularization and Survival

[Expression Clinical Significance of Nm23-H1 and Vessel Endothelium Growth Factor Protein in Nasopharyngeal Carcinoma].

Upregulation of Hypoxia Inducible Factor 1 Alpha Mrna is Associated with Elevated Vascular Endothelial Growth Factor Expression and Excessive Angiogenesis and Predicts A Poor Prognosis in Gastric Carcinoma

Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma.

Prognostic Significance of Vascular Endothelial Growth Factor Protein Levels in T1-2 N0 Laryngeal Cancer Treated with Primary Radiation Therapy

Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer

Expression of HIF-1alpha and VEGF in Colorectal Cancer: Association with Clinical Outcomes and Prognostic Implications.

The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome